Feedback / Questions
sodium oxybate ER (FT218) - Avadel
https://www.nasdaq.com/press-release/avadel-pharmaceuticals-announces-restructuring-to-focus-on-ft218-clinical-development-program-20190207-00541
Feb 7, 2019
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next